• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis.亚硝基磺胺类作为碳酸酐酶抑制剂:一种治疗恰加斯病和利什曼病的有前景的化学类型。
ACS Med Chem Lett. 2018 Nov 27;10(4):413-418. doi: 10.1021/acsmedchemlett.8b00430. eCollection 2019 Apr 11.
2
Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from and .评价硝基芳香苯磺酰胺类化合物对 和 碳酸酐酶的抗原虫活性。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1164-1171. doi: 10.1080/14756366.2019.1626375.
3
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.来自锥虫和利什曼原虫的碳酸酐酶作为抗寄生虫药物靶点。
Bioorg Med Chem. 2017 Mar 1;25(5):1543-1555. doi: 10.1016/j.bmc.2017.01.034. Epub 2017 Jan 24.
4
Are Carbonic Anhydrases Suitable Targets to Fight Protozoan Parasitic Diseases?碳酸酐酶是否适合作为抗原生动物寄生虫病的靶点?
Curr Med Chem. 2018;25(39):5266-5278. doi: 10.2174/0929867325666180326160121.
5
Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles.来自克氏锥虫和杜氏利什曼原虫恰加斯亚种的碳酸酐酶受到苯并硼唑的抑制。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):286-289. doi: 10.1080/14756366.2017.1414808.
6
Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.抑制克氏锥虫碳酸酐酶用于治疗恰加斯病:一个未被充分探索的治疗机会。
Future Med Chem. 2016;8(3):311-24. doi: 10.4155/fmc.15.185. Epub 2016 Feb 22.
7
Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?新型恰加斯病药物的发现:碳酸酐酶是否为抗原生动物药物的靶点?
Expert Opin Drug Discov. 2022 Oct;17(10):1147-1158. doi: 10.1080/17460441.2022.2117295. Epub 2022 Aug 29.
8
Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis.克氏利什曼原虫β-碳酸酐酶的克隆、鉴定及抑制研究,该原生动物寄生虫是引起利什曼病的原因。
J Med Chem. 2013 Sep 26;56(18):7372-81. doi: 10.1021/jm400939k. Epub 2013 Sep 13.
9
Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease.设计、合成及评价羟肟酸衍生物,作为治疗恰加斯病的有前途的药物。
J Med Chem. 2014 Jan 23;57(2):298-308. doi: 10.1021/jm400902y. Epub 2013 Dec 13.
10
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi.一类新型喹唑啉磺酰胺,可作为克氏锥虫α-碳酸酐酶的有效抑制剂。
J Enzyme Inhib Med Chem. 2015;30(4):581-5. doi: 10.3109/14756366.2014.956309. Epub 2014 Nov 6.

引用本文的文献

1
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases.碳酸酐酶作为被忽视热带病治疗的新靶点。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400626. doi: 10.1002/ardp.202400626. Epub 2024 Nov 9.
2
Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant .基于青霉素的碳酸酐酶抑制剂的开发,针对多药耐药。
J Med Chem. 2024 Jun 13;67(11):9613-9627. doi: 10.1021/acs.jmedchem.4c00740. Epub 2024 May 22.
3
Ferrocene-based nitroheterocyclic sulfonylhydrazones: design, synthesis, characterization and trypanocidal properties.基于二茂铁的硝基杂环磺酰基腙类化合物的设计、合成、表征和杀锥虫活性。
J Biol Inorg Chem. 2023 Sep;28(6):549-558. doi: 10.1007/s00775-023-02010-4. Epub 2023 Jul 18.
4
Cloning, characterization, and inhibition of the novel β-carbonic anhydrase from parasitic blood fluke, .从寄生性血吸⾍中克隆、鉴定和抑制新型β-碳酸酐酶。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2184299. doi: 10.1080/14756366.2023.2184299.
5
Diversely -substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of -nitrosulfonamides.取代基多样的苯磺酰胺类化合物与人碳酸酐酶的结合方式存在差异:-亚硝基磺酰胺类化合物的晶体学研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2178430. doi: 10.1080/14756366.2023.2178430.
6
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.关于肼基苯磺酰胺类化合物作为人碳酸酐酶 I、II、IX 和 XII 抑制剂的研究。
Molecules. 2022 Dec 22;28(1):91. doi: 10.3390/molecules28010091.
7
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity.含哌啶基-酰肼脲基和哌啶基-酰肼硫脲基部分的磺酰胺的合成及其对碳酸酐酶 I、II、IX 和 XII 的抑制活性。
Molecules. 2022 Aug 23;27(17):5370. doi: 10.3390/molecules27175370.
8
Inhibition studies of the protozoan α-carbonic anhydrase from with phenols.用酚类物质对原生动物α-碳酸酐酶的抑制研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2417-2422. doi: 10.1080/14756366.2022.2119965.
9
Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy.苯(硫)磷酰胺苯磺酰胺作为人碳酸酐酶 II 和 VII 的有效和选择性抑制剂,可逆转奥沙利铂诱导的神经病变小鼠模型中的痛觉过敏。
J Med Chem. 2020 May 28;63(10):5185-5200. doi: 10.1021/acs.jmedchem.9b02135. Epub 2020 May 14.
10
Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of β-class carbonic anhydrases from bacteria, fungi, and protozoa.膦酰胺是第一个基于磷的锌结合基序,能够抑制细菌、真菌和原生动物的β类碳酸酐酶。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):59-64. doi: 10.1080/14756366.2019.1681987.

本文引用的文献

1
Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.硝呋替莫作为苯硝唑不耐受的慢性恰加斯病患者二线治疗的毒性:在可用选择失败时。
Clin Microbiol Infect. 2018 Dec;24(12):1344.e1-1344.e4. doi: 10.1016/j.cmi.2018.06.006. Epub 2018 Jun 12.
2
Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles.来自克氏锥虫和杜氏利什曼原虫恰加斯亚种的碳酸酐酶受到苯并硼唑的抑制。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):286-289. doi: 10.1080/14756366.2017.1414808.
3
Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets.来自锥虫和利什曼原虫的碳酸酐酶作为抗寄生虫药物靶点。
Bioorg Med Chem. 2017 Mar 1;25(5):1543-1555. doi: 10.1016/j.bmc.2017.01.034. Epub 2017 Jan 24.
4
N-Nitrosulfonamides: A new chemotype for carbonic anhydrase inhibition.N-亚硝基磺酰胺:一种用于碳酸酐酶抑制的新型化学类型。
Bioorg Med Chem. 2016 Aug 15;24(16):3612-7. doi: 10.1016/j.bmc.2016.05.072. Epub 2016 May 30.
5
Binding Mode and Selectivity of Steroids towards Glucose-6-phosphate Dehydrogenase from the Pathogen Trypanosoma cruzi.类固醇对病原体克氏锥虫葡萄糖-6-磷酸脱氢酶的结合模式和选择性
Molecules. 2016 Mar 17;21(3):368. doi: 10.3390/molecules21030368.
6
Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.抑制克氏锥虫碳酸酐酶用于治疗恰加斯病:一个未被充分探索的治疗机会。
Future Med Chem. 2016;8(3):311-24. doi: 10.4155/fmc.15.185. Epub 2016 Feb 22.
7
Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease.羟肟酸衍生物:恰加斯病合理化合物优化的有前途的支架。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):964-73. doi: 10.3109/14756366.2015.1077330. Epub 2015 Aug 31.
8
Bacterial, fungal and protozoan carbonic anhydrases as drug targets.作为药物靶点的细菌、真菌和原生动物碳酸酐酶
Expert Opin Ther Targets. 2015;19(12):1689-704. doi: 10.1517/14728222.2015.1067685. Epub 2015 Aug 1.
9
Inhibition studies of bacterial, fungal and protozoan β-class carbonic anhydrases with Schiff bases incorporating sulfonamide moieties.含磺酰胺基团席夫碱对细菌、真菌和原生动物β-类碳酸酐酶的抑制研究
Bioorg Med Chem. 2015 Aug 1;23(15):4181-4187. doi: 10.1016/j.bmc.2015.06.050. Epub 2015 Jun 26.
10
A new class of quinazoline-sulfonamides acting as efficient inhibitors against the α-carbonic anhydrase from Trypanosoma cruzi.一类新型喹唑啉磺酰胺,可作为克氏锥虫α-碳酸酐酶的有效抑制剂。
J Enzyme Inhib Med Chem. 2015;30(4):581-5. doi: 10.3109/14756366.2014.956309. Epub 2014 Nov 6.

亚硝基磺胺类作为碳酸酐酶抑制剂:一种治疗恰加斯病和利什曼病的有前景的化学类型。

-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis.

作者信息

Bonardi Alessandro, Vermelho Alane Beatriz, da Silva Cardoso Veronica, de Souza Pereira Mirian Claudia, da Silva Lara Leonardo, Selleri Silvia, Gratteri Paola, Supuran Claudiu T, Nocentini Alessio

机构信息

Department of NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Florence, Via U. Schiff 6, 50019 Sesto Fiorentino (Firenze), Italy.

Department of NEUROFARBA, Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSAR, University of Firenze, via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.

出版信息

ACS Med Chem Lett. 2018 Nov 27;10(4):413-418. doi: 10.1021/acsmedchemlett.8b00430. eCollection 2019 Apr 11.

DOI:10.1021/acsmedchemlett.8b00430
PMID:30996772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6466549/
Abstract

and Leishmania spp. are protozoa of the Trypanosomatidae family, respectively, responsible of the neglected tropical disorders (NTDs) Chagas disease and leishmaniasis. The present pharmacotherapy is often ineffective and exhibits serious side effects. The metalloenzyme carbonic anhydrases (CAs, EC 4.2.1.1) recently identified in these protozoans (α-TcCA and β-LdcCA) are novel promising targets for chemotherapeutic interventions. Herein, we report a series of -nitrosulfonamides, as a novel chemotype to yield the target CA isoform selective inhibition over ubiquitous human isozymes. Two derivatives selected among the most active and selective ones for TcCA/LdcCA over off-target CAs were progressed as silver salts to in vitro studies with various developmental forms and spp of and leishmania. Excellent values of parasites growth inhibition (IC) were observed, with some selectivity index (over cytotoxicity for macrophages and Vero cells) being comparable or better than reference drugs. These findings make -nitrosulfonamides and their salts promising lead compounds for a rational optimization of innovative agents for the treatment of Chagas disease and leishmaniasis based on CA inhibition.

摘要

锥虫属和利什曼原虫属分别是锥虫科的原生动物,它们是造成被忽视的热带疾病(NTDs)恰加斯病和利什曼病的病原体。目前的药物治疗往往无效且会产生严重的副作用。最近在这些原生动物中发现的金属酶碳酸酐酶(CAs,EC 4.2.1.1)(α-TcCA和β-LdcCA)是化疗干预的新的有前景的靶点。在此,我们报道了一系列亚硝基磺酰胺,作为一种新型化学类型,对目标CA同工型的抑制作用优于普遍存在的人类同工酶。从对TcCA/LdcCA具有最高活性和选择性的衍生物中挑选出两种,制成银盐,用于对锥虫属和利什曼原虫的各种发育形式进行体外研究。观察到了优异的寄生虫生长抑制(IC)值,一些选择性指数(相对于巨噬细胞和Vero细胞的细胞毒性)与参考药物相当或更好。这些发现使亚硝基磺酰胺及其盐有望成为基于CA抑制作用合理优化治疗恰加斯病和利什曼病创新药物的先导化合物。